MR: GR Balance in Depression
MR: GR Balance in Depression
批准号:
8257538
负责人:
Juan F Lopez
金额:
$38.24万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-15 至 2014-04-30
关键词:
AgonistAnxietyAutomobile DrivingBehavioralBindingBrainCRH geneCircadian RhythmsCorticotropinDataDepressed moodDexamethasoneDoseEmotionalEquilibriumGenesGlucocorticoid ReceptorGlucocorticoidsHormonalHormonesHumanHydrocortisoneHypothalamic structureIndividualLeadLinkMajor Depressive DisorderMental DepressionMineralocorticoid ReceptorNeuronsOrganismPatientsPhenotypePituitary GlandPlacebosPlasmaPlayPortal SystemProsencephalonReceptor ActivationRegulationReportingRoleSerotoninSpironolactoneStimulusStressSystemTimeTrier Social Stress TestWorkbasebody systemdexamethasone suppression testhypercortisolemiahypothalamic-pituitary-adrenal axismedian eminencemouse modelneuroimagingparaventricular nucleusreceptorreceptor downregulationreceptor functionresponse
中文摘要
压力与抑郁症和主要压力激素系统的基础激活增加密切相关,
下丘脑垂体肾上腺(HPA)轴,已发现在约30%的患者的重大
萧条糖皮质激素通过两种不同的受体系统起作用,盐皮质激素受体(MR)
和糖皮质激素受体(GR)。抑郁症的大多数工作都集中在GR与传统的
地塞米松抑制试验(DST)。但是,有很多理由可以预期MR可能是
与抑郁症有关。研究表明,MR与GR活性的平衡不仅在
调节HPA轴,但也特别与脑5-羟色胺系统相关。皮质醇,通过MR发挥作用
已被证明可以调节5 HT 1a受体,而5 HT 1a受体已被证明在大脑中下调。
在尸检和神经影像学研究中发现有严重抑郁症的患者。压力和皮质醇增加,
通过GR起作用,已显示增加5 HT 2a受体,其在患有
萧条我们建议以MR和GR活性来表征抑郁症。我们特别
建议:1扩展我们先前的研究结果,即重度抑郁症患者的MR活动增加,
通过ACTH和皮质醇对螺内酯激发的反应来评估。根据我们的试点数据,我们
假设与对照受试者相比,重度抑郁症患者的MR活动将增加,
对AM和PM螺内酯激发的反应。为了确定通过以下评估的MR活动是否增加:
MR拮抗剂螺内酯伴随GR活性降低的是同一个体,
通过GR激动剂地塞米松评估,在患有重度抑郁症的受试者中。我们假设
抑郁症患者会表现出GR下调,从而增加血浆ACTH和皮质醇水平
地塞米松激发后。结合增强的MR激活,这将导致
MR:GR平衡。3.探讨抑郁症患者高皮质醇血症是否与MR失调有关。我们
假设正常受试者与安慰剂日相比,对2
剂量的螺内酯,而抑郁症患者对2个剂量的反应将显示较小的增加
螺内酯激发试验。4.确定MR是否在人类的压力调节中发挥作用。我们将研究
对特里尔社会压力测试的反应,并确定是否有ACTH和皮质醇的差异
在存在螺内酯与安慰剂的情况下对TSST的应答。我们将在下午进行这些研究
只有当TSST响应最稳健时,以及当MR被认为起主导作用时,
监管作用。
英文摘要
Stress is strongly linked to depression and increased basal activation of the main stress hormone system, the
hypothalamic pituitary adrenal (HPA) axis, has been found in approximately 30% of patients with major
depression. Glucocorticoids act through two different receptor systems, the mineralocorticoid receptor (MR)
and the glucocorticoid receptor (GR). Most work in depression has focused on GR with the traditional
dexamethasone suppression test (DST). But, there are a number of reasons to expect that MR may be
relevant for depression. Studies have suggested that the balance of MR to GR activity is important not only in
regulating the HPA axis, but also particularly relevant to brain serotonin systems. Cortisol, acting through MR
has been shown to regulate 5HT1a receptors, which have been shown to be down-regulated in brain in
patients with major depression in both post-mortem and neuroimaging studies. Stress and increased cortisol,
acting through GR, have been shown to increase 5HT2a receptors, which are also increased in patients with
depression. We propose to characterize major depression in terms of MR and GR activity. Specifically, we
propose: 1 To extend our previous findings of increased MR activity in subjects with major depression, as
assessed by the ACTH and cortisol response to a spironolactone challenge. Based on our pilot data, we
hypothesize that MR activity will be increased in patients with major depression compared to control subjects in
response to both AM and PM spironolactone challenge. To determine if increased MR activity as assessed by
the MR antagonist spironolactone is accompanied by decreases in GR activity is the same individuals, as
assessed by the GR agonist dexamethasone, in subjects with major depression. We hypothesize that
depressed patients will show GR downregulation and thus increased plasma ACTH and cortisol levels
following dexamethasone challenge. Combined with enhanced MR activation, this will lead to an alteration in
MR:GR balance. 3.To determine if MR dysregulation is involved in the hypercortisolemia of depression. We
hypothesize that normal subjects will show increased cortisol, compared to placebo day, in response to 2
doses of spironolactone while depressed patients will show a smaller increase in response to the 2 dose
spironolactone challenge. 4. To determine if MR plays a role in stress regulation in humans. We will examine
response to the Trier Social stress test and determine if the there are differences in the ACTH and cortisol
response to the TSST in the presence of spironolactone vs placebo. We will conduct these studies in the PM
only, the time when the TSST response is most robust, and when MR is believed to play the predominant
regulatory role.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jpsychires.2012.11.002
发表时间:
2013-03
期刊:
JOURNAL OF PSYCHIATRIC RESEARCH
影响因子:
4.8
作者:
[Medina, Adriana, Seasholtz, Audrey F., Sharma, Vikram, Burke, Sharon, Bunney, William, Jr., Myers, Richard M., Schatzberg, Alan, Akil, Huda, Watson, Stanley J.]
通讯作者:
Watson, Stanley J.
Maternal behavior and effects of paternal affiliation in 5-HT1a overexpressing mi
-
批准号:7462642
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2009
-
负责人:Juan F Lopez
-
依托单位:
MR: GR Balance in Depression
-
批准号:7843493
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2009
-
负责人:Juan F Lopez
-
依托单位:
MR: GR Balance in Depression
-
批准号:8063943
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2009
-
负责人:Juan F Lopez
-
依托单位:
Maternal behavior and effects of paternal affiliation in 5-HT1a overexpressing mi
-
批准号:7862324
-
项目类别:
-
资助金额:$19.15万
-
财政年份:2009
-
负责人:Juan F Lopez
-
依托单位:
MR: GR Balance in Depression
-
批准号:7646095
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2009
-
负责人:Juan F Lopez
-
依托单位:
Stress Regulation of 5HT Receptors and the HPA Axis
-
批准号:6327367
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2001
-
负责人:Juan F Lopez
-
依托单位:
Stress Regulation of 5HT Receptors and the HPA Axis
-
批准号:6879720
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2001
-
负责人:Juan F Lopez
-
依托单位:
Stress Regulation of 5HT Receptors and the HPA Axis
-
批准号:6539162
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2001
-
负责人:Juan F Lopez
-
依托单位:
Stress Regulation of 5HT Receptors and the HPA Axis
-
批准号:6639209
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2001
-
负责人:Juan F Lopez
-
依托单位:
Stress Regulation of 5HT Receptors and the HPA Axis
-
批准号:6719520
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2001
-
负责人:Juan F Lopez
-
依托单位:
SEROTONIN AND HPA AXIS INTERACTIONS IN SUICIDE BRAINS
-
批准号:2445416
-
项目类别:
-
资助金额:$12.82万
-
财政年份:1995
-
负责人:Juan F Lopez
-
依托单位:
SEROTONIN AND HPA AXIS INTERACTIONS IN SUICIDE BRAINS
-
批准号:2240630
-
项目类别:
-
资助金额:$12.26万
-
财政年份:1995
-
负责人:Juan F Lopez
-
依托单位:
SEROTONIN AND HPA AXIS INTERACTIONS IN SUICIDE BRAINS
-
批准号:2889818
-
项目类别:
-
资助金额:$13.82万
-
财政年份:1995
-
负责人:Juan F Lopez
-
依托单位:
SEROTONIN AND HPA AXIS INTERACTIONS IN SUICIDE BRAINS
-
批准号:2674380
-
项目类别:
-
资助金额:$13.09万
-
财政年份:1995
-
负责人:Juan F Lopez
-
依托单位:
SEROTONIN AND HPA AXIS INTERACTIONS IN SUICIDE BRAINS
-
批准号:2240631
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1995
-
负责人:Juan F Lopez
-
依托单位:
NEUROTRANSMITTER CONTROL OF THE PITUITARY POMC SYSTEM
-
批准号:3052879
-
项目类别:
-
资助金额:$3.1万
-
财政年份:1988
-
负责人:Juan F Lopez
-
依托单位:
NEUROTRANSMITTER CONTROL OF THE PITUITARY POMC SYSTEM
-
批准号:3052878
-
项目类别:
-
资助金额:$2.9万
-
财政年份:1988
-
负责人:Juan F Lopez
-
依托单位:
海外基金